Farnum Rhonda

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$172,536.90

Insider Activity of Farnum Rhonda

According to the SEC Form 4 filings, Farnum Rhonda, being in a position of

  1. SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6632 shares for $61,102,
    over all time since 2022-02-28, has bought 0 shares, and sold 17666 shares for $172,537.

The largest sale of all time was on 2023-03-09 and amounted to 4000 shares of Theravance Biopharma, Inc. for $40,800.

Biography of Farnum Rhonda

No biography is available at this moment.

2024-07-10SaleTheravance Biopharma, Inc.
TBPH
SVP, COMM & MEDICAL AFFAIRS
4,000
0.0088%
$9.00$36,0000%
2024-02-22SaleTheravance Biopharma, Inc.
TBPH
SVP, COMM & MEDICAL AFFAIRS
1,254
0.0025%
$8.71$10,922+1.33%
2023-11-21SaleTheravance Biopharma, Inc.
TBPH
SVP, COMM & MEDICAL AFFAIRS
1,378
0.0026%
$10.29$14,180-11.95%
2023-08-22SaleTheravance Biopharma, Inc.
TBPH
SVP, COMM & MEDICAL AFFAIRS
1,807
0.0034%
$9.47$17,112-1.27%
2023-06-08SaleTheravance Biopharma, Inc.
TBPH
SVP, COMM & MEDICAL AFFAIRS
1,790
0.0028%
$11.13$19,923-14.26%
2023-03-09SaleTheravance Biopharma, Inc.
TBPH
SVP, COMM & MEDICAL AFFAIRS
4,000
0.0063%
$10.20$40,800-1.51%
2022-05-20SaleTheravance Biopharma, Inc.
TBPH
SVP, COMM & MEDICAL AFFAIRS
1,081
0.0014%
$8.93$9,653+16.88%
2022-02-28SaleTheravance Biopharma, Inc.
TBPH
SVP, COMM & MEDICAL AFFAIRS
2,356
0.0032%
$10.16$23,947-2.09%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.